The European Society of Gene and Cell Therapy (ESGCT) is a leading organization committed to support scientists and clinicians involved with basic and translational research on gene transfer and clinical applications of gene and cell therapy. Europe has long been at the forefront of such endeavors, thanks to the efforts of highly skilled and passionate scientists, the close collaboration within our scientific community, the constant involvement of many national centers of excellence in clinical care, the support of the European Union funding system, and the close attention of Regulatory Authorities at the national and EU level. Read more
The 2015 ESGCT and FSGT Collaborative Congress has now come to an end!
View Congress photos HERE
View the Germline Gene Editing Debate video HERE
Coming soon: snapshots of the Education Day, this year's award winners, and other highlights of the congress.
Am email has gone out to all participants inviting them to complete the survey, and then receive their certificate of attendance. If you attended and have not yet received this email (and you've checked your spam folder), let us know...
The European Society of Gene and Cell Therapy (ESGCT) promotes basic and clinical research in gene therapy, cell therapy, and genetic vaccines by facilitating education, the exchange of information and technology and by serving as a professional adviser to stakeholder communities and regulatory bodies in Europe.
To keep up to date with announcements and news, including being alerted when registration for the Madrid congress is open, enter your email address in the 'Keep Informed' box at the bottom of this page.
We look forward to seeing you in Helsinki.